The association between social risk profile and self-reported severe headache or migraine with all-cause mortality risk: A machine learning-based prediction model and interpretability analysis - Report - MDSpire

The association between social risk profile and self-reported severe headache or migraine with all-cause mortality risk: A machine learning-based prediction model and interpretability analysis

  • By

  • Mengjie Zhao

  • Jing Cao

  • Zirong Li

  • Fang Lu

  • Qiuyan Li

  • July 4, 2026

  • 0 min

Share

Linking Social Risk Factors to Severe Headaches and Mortality

Overview

This study introduces a Social Risk Profile that combines eight social factors, revealing a strong association with increased mortality in individuals reporting severe headaches or migraines.

Background

Migraine is a prevalent primary headache disorder affecting over one billion people globally, with significant socioeconomic implications. The relationship between social risk factors and migraine prevalence and mortality is underexplored.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The study developed a comprehensive Social Risk Profile (SRP) encompassing eight key social factors.
  • A higher SRP score is linked to an increased risk of death in individuals with self-reported severe headaches or migraines.
  • Explainable machine learning techniques were utilized to assess feature contributions to risk stratification.
  • There is a bidirectional relationship between migraine and food insecurity.
  • Healthcare utilization and direct medical spending are significantly higher in migraine patients compared to matched controls.

Clinical Implications

Healthcare providers should consider social risk factors when assessing and managing patients with severe headaches or migraines. Addressing these social determinants may improve health outcomes and reduce mortality risk in this population.

Conclusion

The findings underscore the critical role of social determinants in the health of individuals with migraines, suggesting that comprehensive care strategies should extend beyond medical treatment.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. American Headache Society, Updated ER Migraine Guidelines Provide… , 2025 -- Guidance for clinicians
  5. American College of Physicians, Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings, 2025 -- Clinical Guideline
  6. Canadian Headache Society, Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis, 2025 -- Clinical Guidance
  7. DIGITAL HEALTH — Implication of machine learning models versus traditional models for the prediction of suicidal thoughts or ideation in west of Iran; data mining approaches on a population-based cross-sectional study
  8. Updated ER Migraine Guidelines Provide… | American Headache Society
  9. Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians - PubMed
  10. Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis*
  11. Setting higher standards for migraine prevention: A position statement of the International Headache Society
  12. Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials - PubMed
  13. Efficacy and safety of CGRP monoclonal antibodies in chronic migraine: a systematic review integrating randomized and real-world evidence - PubMed
  14. ZAVZPRET (zavegepant) nasal spray
  15. https://thejournalofheadacheandpain.biomedcentral.com/counter/pdf/10.1186/s10194-025-02164-3.pdf
  16. The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) Study - PMC
  17. Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study - Therese Wennersten, Jonatan D. Lindh, A. Ingela M. Nilsson Remahl, Marine L. Andersson, Mia von Euler, Karin Wirdefeldt, Isabella Ekheden, 2025

Original Source(s)

Related Content